INDEXED STUDIES
Neuropeptide Y (NPY) — Indexed Studies
50 most recent studies indexed by PSI from PubMed and clinical databases
Showing 50 of 50 studies
Efficacy and safety of peptide radionuclide therapy with (177)Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N).
Okamoto K, Hijioka S, Kobayashi N et al.
Pituitary dysfunction in trans-sellar encephalocele: a two-case report and a literature review.
Amano K, Seki Y, Koizumi S et al.
Reduced high-sensitivity C-reactive protein levels following weekly somapacitan in adults with growth hormone deficiency: a prospective pilot study.
Seki Y, Morimoto S, Ikemoto M et al.
Efficacy and safety of endoscopic hemostasis with a self-assembling peptide solution in patients with colonic diverticular bleeding: a multicenter pilot study (with video).
Yamaguchi D, Tominaga N, Mori G et al.
Isolated adrenocorticotropic hormone deficiency presenting with arthritis: A case report.
Yamashita Y, Sato S, Nii K et al.
Polycystic ovary syndrome in a patient with type B insulin resistance syndrome can improve with glucocorticoid treatment: a case report and literature review.
Watanabe T, Okabe S, Sakamoto S
[Efficiency and safety of Prostatex in patients with chronic prostatitis/chronic pelvic pain syndrome. Results of the phase IV PRESTIGE trial].
Morozov AO, Vovdenko SV, Maltsagova PS et al.
INFLUENCE OF ADDING ZINC ARGINYLE-GLYCINATE TO IMPROVE EFFICACY OF BIOREGULATORY PEPTIDES OF THE PROSTATE GLAND IN TREATMENT OF PATIENTS WITH IMPAIRED SPERM PARAMETERS.
Rybalov M, Borovets S, Petlenko S et al.
Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.
Hara T, Uemoto R, Sekine A et al.
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.
Tsuda M, Hirata A, Tokunaga S et al.
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial.
Kadowaki T, Chin R, Ozeki A et al.
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes.
Hara T, Uemoto R, Sekine A et al.
Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study.
Quero CD, Manonelles P, Fernández M et al.
Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index.
Mitsui Y, Kuroda A, Ishizu M et al.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Ito T, Fujimori N, Honma Y et al.
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L, Ramos-Alvarez I, Ito T et al.
Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment.
Hirayama T, Ikegami T, Honda A et al.
The Effective Treatment with Cyclosporine of a Ulcerative Colitis Patient with Concurrent Idiopathic Thrombocytopenic Purpura Who Subsequently Developed Spontaneous Pneumomediastinum.
Iwasa T, Nakamura K, Ihara E et al.
Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors.
Ito T, Honma Y, Hijioka S et al.
Evaluation of circadian phenotypes utilizing fibroblasts from patients with circadian rhythm sleep disorders.
Hida A, Ohsawa Y, Kitamura S et al.
Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors.
Miki M, Ito T, Hijioka M et al.
Japan Fracture Observational Study (JFOS): patient characteristics and interim data on the use of daily teriparatide in Japanese patients with osteoporosis.
Soen S, Fujiwara S, Takayanagi R et al.
Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
Ogawa E, Furusyo N, Kajiwara E et al.
Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure.
Ogawa E, Furusyo N, Dohmen K et al.
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
Miyazaki Y, Fujiwara H, Asai H et al.
Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.
Shikata H, Yakushijin Y, Yamanouchi J et al.
Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Ito T, Okusaka T, Nishida T et al.
Reduced arterial stiffness in patients with acromegaly: non-invasive assessment by the cardio-ankle vascular index (CAVI).
Matsuda Y, Kawate H, Matsuzaki C et al.
WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer.
Shirakata T, Oka Y, Nishida S et al.
[Pathogenetic characteristics of generalized parodontitis in elderly patients].
Malezhik MS, Pinelis IuI, Malezhik LP
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
Ito T, Nakamura T, Fujimori N et al.
Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.
Fujimura M, Akaike M, Iwase T et al.
[Efficacy of vitaprost forte in patients with prostatic adenoma].
Miller AM, Iaroshenko VP, Soroka PV et al.
[Vitaprost forte efficacy in patients with prostatic adenoma].
Tkachuk VN, Tkachuk IN
Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
Sumida Y, Nakamura K, Kanayama K et al.
Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions.
Yoshimitsu M, Fujiwara H, Ozaki A et al.
Investigation of hyperuricemia during pegylated-interferon-alpha2b plus ribavirin combination therapy in patients with chronic hepatitis C.
Yamashita N, Enjoji M, Kotoh K et al.
Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study.
Matsumoto T, Shiraki M, Hagino H et al.
Re-evaluation of antitumor effects of combination chemotherapy with interferon-alpha and 5-fluorouracil for advanced hepatocellular carcinoma.
Enjoji M, Morizono S, Kotoh K et al.
Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma.
Jalili A, Ozaki S, Hara T et al.
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
Choi I, Abe Y, Ohtsuka R et al.
High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.
Takamori N, Azuma H, Kato M et al.
Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome.
Endo I, Mitsui T, Nishino M et al.
Clinical implications of aldosterone responsiveness to adrenocorticotropic hormone stimulation in two major subtypes of primary aldosteronism.
Watanabe D, Morimoto S, Morishima N et al.
Prospective study of anamorelin in pancreatic cancer cachexia: Clinical and translational insights into response heterogeneity.
Matsukane R, Minami H, Fujimori N et al.
Ozone therapy and the role of the glutathione pathway.
Chirumbolo S, Franzini M, Tirelli U et al.
A case of gastric-localized juvenile polyposis syndrome with SMAD4 mosaic variant presenting as a slowly progressive phenotype.
Fukuya H, Sasaki T, Ihara E et al.
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study.
Oyama K, Nakata K, Abe T et al.
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse.
Nishioka K, Ogino H, Ihara E et al.
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
Inoue Y, Tenshin H, Teramachi J et al.
Considering peptide therapy?
Find a vetted physician in our directory who specializes in evidence-based peptide protocols.
Find a Physician